Skip to content

Jujuboside A ameliorates T2DM-associated MASH: Suppression of YY1/FAS axis-mediated hepatic de novo fatty acid biosynthesis.

Nov 2026 · Journal of Nutritional Biochemistry · pp. 110532 · 0 citations · 64 references
Medicine

Abstract

Metabolic dysfunction-associated steatohepatitis (MASH) in type 2 diabetes mellitus (T2DM) represents a progressive subtype of metabolic dysfunction-associated steatotic liver disease (MASLD), and is predominantly driven by dysregulated hepatic fatty acid (FA) metabolism. Although Jujuboside A (Ju A), a major bioactive triterpene saponin isolated from Ziziphus jujuba Mill. (sour jujube), exhibits hepatoprotective properties, its precise regulatory mechanisms underlying T2DM-associated MASH remain poorly defined. This study investigated the dose-dependent protective effects and molecular mechanisms of Ju A using both in vivo and in vitro models. Combining targeted FA profiling and long-chain FAs (LCFAs)-specific metabolomics, alongside chromatin immunoprecipitation (Ch-IP), luciferase reporter assays, molecular docking with dynamics simulations, and Yin Yang 1 (YY1) gain-of-function and fatty acid synthase (FAS) inhibition (C75) studies, we characterized Ju A-mediated metabolic reprogramming and molecular targets involved. Ju A treatment markedly ameliorated MASH and hepatic lipid deposition in diabetic mice by restoring dysregulated hepatic FA homeostasis, particularly by blocking de novo lipogenesis (DNL)-derived LCFA accumulation. Mechanistically, Ju A exerted these effects by blocking the nuclear translocation of YY1. This inhibition diminished YY1 binding to the FAS promoter, subsequently downregulating FAS expression and inhibiting aberrant hepatic de novo FA biosynthesis. Collectively, these findings demonstrated that Ju A ameliorated T2DM-associated MASH by restoring hepatic FA homeostasis via inactivation of the YY1-FAS axis, highlighting its promising therapeutic potential against diabetic liver complications.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.